Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-03-20
1980-05-13
Turk, Arnold
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
232303, 23230B, 23920, 424 15, G01N 3316, A61K 4300
Patent
active
042028752
ABSTRACT:
Components for a biochemical assay system for diagnosis of myasthenia gravis in humans. Acetylcholine receptor protein is extracted from non-human mammalian fetal muscle tissue. The acetylcholine receptor protein is then used in a bio-assay system as a complex of the acetylcholine receptor protein and a toxin labeled with a radioactive isotope.
REFERENCES:
patent: 4033722 (1977-07-01), Lindstrom
Fambrough et al., "Neuromuscular Junction in Myasthenia Gravis Decreased Acetylcholine Receptors", Science, vol. 182, Oct. 1973, pp. 293-295.
Almon et al., "Serum Globulin in Myasthenia Gravis: Inhibition of Bungarotoxin to Acetylcholine Receptors", Science, vol. 186, No. 4158, Oct. 1974, pp. 55-57.
The Salk Institute for Biological Studies
Turk Arnold
LandOfFree
Receptor for biochemical assay system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor for biochemical assay system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor for biochemical assay system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929755